Case Comp Cancer Ctr
@caseccc
Creating synergy between CWRU, UH, & CC to challenge the boundaries of cancer knowledge, unlock novel cancer research, and transform the cancer care landscape.
ID: 234786406
http://case.edu/cancer 06-01-2011 15:27:52
5,5K Tweet
2,2K Followers
1,1K Following
New article in LSA demonstrates how a shift of arginine metabolism from polyamine synthesis to nitric oxide synthesis induces reprogramming of macrophages from pro-tumor M2 to anti-tumor M1 types UToledo Medicine Case Comp Cancer Ctr hubs.la/Q02MR7f60
Stanton Gerson, MD, dean of CWRU School of Medicine and member of Case CCC, weighs in on how much radiation Starliner astronauts may have been exposed to while waiting to come home ABC11 EyewitnessNews abc11.com/how-radiation-…
Cleveland is the place to be to conduct brain tumor research! The CLE contingent at #AARN24 - a meeting for researchers who have been funded by American Brain Tumor Association. CLE researchers representing Case Comp Cancer Ctr Cleveland Clinic Lerner Research Institute & CWRU School of Medicine made up >10% of attendees! #ABTAResearcher
Great ride around Cleveland this morning to support VeloSano as part of the Case Comp Cancer Ctr team! Thanks to all the riders and sponsors! (Including Cleveland Guardians - riding through the stadium was a highlight!) #biketocure #Velosano
Join President's Cancer Panel for a 2-day virtual event exploring opportunities across academia, public & private sectors to optimize the clinical care & research workforce- critical partners in our mission to #EndCancerAsWeKnowIt. Learn more: go.nih.gov/8nf2WTz. #NationalCancerPlan
Ankit Mangla, MD, expands on key survival data from the phase 2/3 RELATIVITY-047 trial in previously untreated, unresectable, or metastatic melanoma. Ankit Mangla, MD Case Comp Cancer Ctr #melsm #oncology #MedTwitter onclive.com/view/dual-chec…
Sacituzumab govitecan demonstrated activity in patients with ES-SCLC in the phase 2 TROPiCS-03 trial. Presented at #WCLC24 by Dr Afshin Dowlati from Case Comp Cancer Ctr. #lcsm cancertherapyadvisor.com/reports/sacitu…
On the #AACRBlog Bianca Islam, MD, PhD, MSc (she/her) examines how social determinants of health impact cancer patients, and some of the things being done to address these issues and close gaps in care: bit.ly/4el8B9Y Case Comp Cancer Ctr University Hospitals
Ankit Mangla, MD, expands on key survival data from the phase 2/3 RELATIVITY-047 trial in previously untreated, unresectable, or metastatic melanoma. Ankit Mangla, MD Case Comp Cancer Ctr #melsm #oncology #MedTwitter onclive.com/view/dual-chec…
Case CCC Trainee Associate Member Bianca Islam, MD, PhD, MSc (she/her) will be participating in an important discussion today about cancer workforce diversity and addressing the needs of the #NationalCancerPlan meeting. Check out prescancerpanel.cancer.gov to view all the amazing presenters and topics.
Join Jed Ian Taxel Foundation for Rare Cancer Research for a night of exploring fine wines to support transformative rare cancer research at Case Western Reserve's Case Comp Cancer Ctr. case.edu/medicine/givin…
📅 A year ago today, momelotinib was approved in the US for patients with #myelofibrosis plus #anemia. 📝 Check out results from the MOMENTUM study, led by Aaron Gerds MD, MS, of Case Comp Cancer Ctr, that supported its approval. ➡️ buff.ly/4cfZFBI
The current treatment paradigm of non-clear cell #RCC. Presented by Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr. #ESMO24 written coverage by Rashid K. Sayyid on UroToday > bit.ly/3XsH8fP ESMO - Eur. Oncology
